Hillegass Ronald MD Smithfield, RI - 02917

Hillegass Ronald MD is categorized under Internal Medicine Doctors in Smithfield, RI and active since 2010.

Hillegass Ronald MD was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Ronald Hillegass at the company’s single location by writing to 25 Thurber Boulevard Unit 6, Smithfield, Rhode Island RI 02917 or by phoning (401) 404-2975. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Hillegass Ronald MD
Contact Person: Ronald Hillegass
Address: 25 Thurber Boulevard Unit 6, Smithfield, Rhode Island 02917
Phone Number: (401) 404-2975
Website Address: bsnidoctors.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Hillegass Ronald MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Ronald Hillegass for inquiries that concern Hillegass Ronald MD by calling the company number (401) 404-2975, as your correspondence is most welcome. Additionally, the physical location of the single location of Hillegass Ronald MD can be found at the coordinates 41.91147,-71.52053 as well as the street address 25 Thurber Boulevard Unit 6 in Smithfield, Rhode Island 02917.

For its online presence, you may visit Hillegass Ronald MD’s website at bsnidoctors.com and engage with its social media outlets through on Twitter and on Facebook.